Brooks Laboratories Ltd Share Price

₹94.35 -2.25 (-2.33%) BSE
as updated on 19-Dec-2025 16:59 | Sector - Healthcare

Day Range

  • Day's Low:93.00
  • Day's High:96.00

  • 52 Week Low93.90
  • 52 Week High202.80

Brooks Laboratories Ltd's key Fundamentals

Market Cap ₹285 Cr.
P/E Ratio 40.7
TTM EPS 2.4
P/B Ratio 2.37
ROE 3.19
Debt to Equity 0.05
Face Value 10
BVPS 40.7
3 Year Sales Growth 2.36%

Brooks Laboratories Ltd's Share Price Returns

1 Day -2.33%
1 Week -3.30%
1 Month -8.20%
3 Months -35.80%
6 Months -26.90%
1 Years -41.50%
3 Years -14.30%
5 Years 45.00%
10 Years 0%

Financial Ratio Analysis

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

Check our DeciZen before investing

Check Stock Quality
Check Stock Valuation
Check Price Trend

Brooks Laboratories Ltd Shareholding Pattern

Promoters

(52.62%)

Institutions

(9.91%)

Non-Institutions

(37.48%)

Pledged shares as % of Promoter's holding (%)

(0.00%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Balance Sheet

(All Figures are in Crores.)

Profit And Loss

(All Figures in Cr. Adjusted EPS in Rs.)

Cash Flow

(All Figures are in Crores.)

About Brooks Laboratories Ltd

The Company was originally incorporated as Brooks Laboratories Limited on January 23, 2002. Company was initially promoted for manufacturing of latest molecules in Injectables, tablets and dry syrups for the domestic customers. The Company set up a facility for manufacturing Tablets, Dry Syrup and Injectables, which was supported by a research and development centre at Baddi, Himachal Pradesh. The Company started its commercial production in the month of June 2006 and became profitable from the very first year of its production.

The company has set up a well equipped manufacturing unit at Baddi, Himachal Pradesh in the year 2006 and has been awarded a G.M.P Certification for following Good Manufacturing Practices under “Revised Schedule M” of Drugs & Cosmetics Rules, 1945 in respect of various categories of Tablets, Capsules, Liquid Orals, Dry Syrups, SVP (Liquid & Dry) and Ophthalmic Section by The Health & Family Welfare Department, Himachal.

Company’s manufacturing facility at Baddi is capable of manufacturing products confirming to TRS 908 of 2003 (WHO GMP) standards. Its Quality Management System at the factory at Baddi is certified as complying to ISO 9001:2008.

Product of the company

The company has wide range of products catering to critical care segment in Parental Section like Beta Lactam, Cephalosporin & General dry powder Injectables, Ampoules and Liquid vials. These products are manufactured in accordance with highest international standards in facilities as per norms of WHO-GMP & ISO 9000-2008.

Some of the product categories are:

  • Beta Lactum
  • Cephalosporins
  • Carbapenems
  • General Injectable (Dry Powder)
  • General Injectable (Liquid)
  • Cortico Steroids
Read More Read Less
Read More Read Less

Investment related blogs

Day Range

  • Day's Low: 93.00
  • Day's High: 96.00

  • 52 Week Low93.90
  • 52 Week High202.80

Brooks Laboratories Ltd's key Fundamentals

Market Cap ₹285 Cr.
P/E Ratio 40.7
TTM EPS 2.4
P/B Ratio 2.37
ROE 3.19
Debt to Equity 0.05
Face Value 10
BVPS 40.7
3 Year Sales Growth 2.36%

Brooks Laboratories Ltd's Share Price Returns

1 Day -2.33%
1 Week -3.30%
1 Month -8.20%
3 Months -35.80%
6 Months -26.90%
1 Years -41.50%
3 Years -14.30%
5 Years 45.00%
10 Years 0%

Investment related blogs

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×